Immutopics

Immutopics manufactures diagnostic kits for pre-clinical studies in bone and mineral metabolism for human.

Launch date

1989

Market cap

Enterprise valuation

€5m (Public information from Mar 2016)

San Clemente California (HQ)

Date	Investors	Amount	Round
Mar 2016	Quidel	$5.5m Valuation: $5.5m	Acquisition
Total Funding		-

Tech stackLearn more about the technologies and tools that this company uses.

Recent News about Immutopics